Clinical Trial Update: A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating HX008 versus chemotherapy as first-line therapy for MSI-H/dMMR metastatic colorectal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• HX008

Snippet

Sponsor: Taizhou Hanzhong biomedical co. LTD | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: RECRUITING